This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Poised for Breakouts

pSivida

One stock in the biotechnology and drugs complex that's trading within range of a major breakout trade is pSivida (PSDV - Get Report), which, together with its subsidiaries, develops drug delivery products for treatment of back-of-the-eye diseases that are administered by implantation, injection, or insertion. This stock is off to a monster start in 2012 with shares up over 110%.

If you look at the chart for pSivida, you'll see that this stock dropped pretty hard once it hit its April high of $2.55, since shares then dropped to a low of $1.76 a share in June. During that sharp slide lower, shares of PSDV were making lower highs and lower lows, which is bearish technical price action. That said, during the last month shares of pSivida have formed a double bottom chart pattern at around $1.76 to $1.78 a share. That bottom brought in buyer who have pushed the stock back above both its 50-day and 200-day moving averages. Now shares of pSivida are trading within range of a major breakout trade.

>>Hot Biotech Stocks Traded by Hedge Funds

Traders should now look for long-biased trades in PSDV if it can manage to take out some major overhead resistance levels at $2.80 to $2.85 a share with high volume. Look for a sustained move or close above those levels with volume that's near or above its three-month average action of 70,847 shares. If we get that action soon, then PSDV has tremendous upside since the next significant overhead resistance level sits at $4 to $4.81 a share.

One could look to buy PSDV off weakness and simply use a stop at around its 200-day moving average of $2.18 a share. Or you could buy off strength and get long once PSDV takes out $2.80 to $2.85 with volume, and then simply use a stop at around $2.60 to $2.55 a share.

4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
LNG $75.18 0.00%
KTOS $5.58 0.00%
MRGE $4.60 0.00%
PSDV $4.01 0.00%
SODA $21.47 0.00%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs